全文获取类型
收费全文 | 1523篇 |
免费 | 84篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 119篇 |
妇产科学 | 50篇 |
基础医学 | 238篇 |
口腔科学 | 34篇 |
临床医学 | 128篇 |
内科学 | 292篇 |
皮肤病学 | 83篇 |
神经病学 | 90篇 |
特种医学 | 26篇 |
外科学 | 103篇 |
综合类 | 19篇 |
预防医学 | 125篇 |
眼科学 | 68篇 |
药学 | 119篇 |
中国医学 | 19篇 |
肿瘤学 | 88篇 |
出版年
2024年 | 1篇 |
2023年 | 20篇 |
2022年 | 27篇 |
2021年 | 55篇 |
2020年 | 37篇 |
2019年 | 53篇 |
2018年 | 74篇 |
2017年 | 50篇 |
2016年 | 57篇 |
2015年 | 59篇 |
2014年 | 96篇 |
2013年 | 102篇 |
2012年 | 159篇 |
2011年 | 141篇 |
2010年 | 70篇 |
2009年 | 59篇 |
2008年 | 108篇 |
2007年 | 56篇 |
2006年 | 72篇 |
2005年 | 70篇 |
2004年 | 59篇 |
2003年 | 57篇 |
2002年 | 38篇 |
2001年 | 7篇 |
2000年 | 4篇 |
1999年 | 3篇 |
1998年 | 5篇 |
1997年 | 9篇 |
1996年 | 9篇 |
1995年 | 4篇 |
1994年 | 7篇 |
1993年 | 5篇 |
1992年 | 2篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 6篇 |
1988年 | 2篇 |
1986年 | 1篇 |
1984年 | 2篇 |
1983年 | 4篇 |
1982年 | 2篇 |
1981年 | 1篇 |
1979年 | 2篇 |
1978年 | 1篇 |
1977年 | 2篇 |
1976年 | 2篇 |
1975年 | 1篇 |
1966年 | 1篇 |
排序方式: 共有1611条查询结果,搜索用时 0 毫秒
51.
52.
Carlo W. Cereda Giovanni Bianco Michael Mlynash Nicole Yuen Abid Y. Qureshi Archana Hinduja Seena Dehkharghani Adam E. Goldman-Yassen Kevin Li-Chun Hsieh Dan-Victor Giurgiutiu Dan Gibson Emmanuel Carrera Fana Alemseged Tobias D. Faizy Jens Fiehler Marco Pileggi Bruce Campbell Gregory W. Albers Jeremy J. Heit 《Annals of neurology》2022,91(1):23-32
53.
Sharma KK Ayyagiri A Dhole TN Prasad KN Kishore J 《Indian journal of pathology & microbiology》2007,50(2):453-457
Renal transplant is usually performed at the end stage of renal disease. Most of the transplant recipients become susceptible to infections due to chronic uremia, protein depletion, anemia and administration of immunosuppressive drugs. It is a retrospective study of 510 post renal transplant recipients. 378 (74%) renal transplant recipients suffered from the infections. Most common site of infection was urinary tract infection (53%). Out of 26% of wound infections, the deep wound infection (23%) was six times higher than superficial wound infection (3.5%). Chest infection and bacteraemia were noticed to be 18% and 8%, respectively. The common isolate was Escherichia coli (160) followed by Staphylococcus aureus (140), Enterococcus (86) and Pseudomonas (69). 相似文献
54.
DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity 总被引:3,自引:0,他引:3
Lin CT Tsai YC He L Yeh CN Chang TC Soong YK Monie A Hung CF Lai CH 《Immunology letters》2007,114(2):86-93
DNA vaccination has emerged as a promising strategy for cancer immunotherapy. However, since DNA vaccines have low immunogenicity, various strategies have been developed to enhance the potency of DNA vaccines. In the current study, we aim to determine whether the potency of the DNA vaccine encoding human papillomavirus type 16 (HPV-16) E7 antigen can be enhanced by IL-2. We have generated a DNA vaccine encoding IL-2 linked to HPV-16 E7 antigen. Our results indicate that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the highest frequency of E7-specific CD8(+) T cells. We also found that the DNA vaccine encoding a fusion of IL-2 and E7 proteins generated the strongest protective as well as therapeutic anti-tumor effect against E7-expressing tumors. In addition, it was observed that CD8(+) T cells were mainly responsible for the antitumor effect generated by the DNA vaccine encoding a fusion of IL-2 and E7 proteins. Thus, we conclude that the linkage of IL-2 to HPV-16 E7 antigen significantly enhances the DNA vaccine potency against E7-expressing tumors. Our strategy may potentially be used in other antigenic systems to control infectious diseases and/or cancer. 相似文献
55.
HIV-1 integrates into resting CD4+ T cells even at low inoculums as demonstrated with an improved assay for HIV-1 integration 总被引:1,自引:1,他引:0
Human Immunodeficiency Virus Type 1 (HIV-1) establishes a latent reservoir early in infection that is resistant to the host immune response and treatment with highly active antiretroviral therapy (HAART). The best understood of these reservoirs forms in resting CD4(+) T cells. While it remains unclear how reservoirs form, a popular model holds that the virus can only integrate in activated CD4(+) T cells. Contrary to this model, our previous results suggest that HIV-1 can integrate directly into the genomes of resting CD4(+) T cells. However, a limitation of our previous studies was that they were conducted at high viral inoculum and these conditions may lead to cellular activation or saturation of restriction factors. In the present study, we tested if our previous findings were an artifact of high inoculum. To do this, we enhanced the sensitivity of our integration assay by incorporating a repetitive sampling technique that allowed us to capture rare integration events that occur near an Alu repeat. The new technique represents a significant advance as it enabled us to measure integration accurately down to 1 provirus/well in 15,000 genomes--a 40-fold enhancement over our prior assay. Using this assay, we demonstrate that HIV can integrate into resting CD4(+) T cells in vitro even at low viral inoculum. These findings suggest there is no threshold number of virions required for HIV to integrate into resting CD4(+) T cells. 相似文献
56.
Sharad Kharel Archana Gautam Andreas Dickescheid Say Chye Joachim Loo 《Pharmaceutical research》2018,35(10):185
Purpose
Peptides are gaining significant interests as therapeutic agents due to their high targeting specificity and potency. However, their low bioavailability and short half-lives limit their massive potential as therapeutics. The use of dense, solid particles of biodegradable polymer as a universal carrier for peptides also has its challenges, such as inefficient peptide release and low bioactivity. In this paper, it was established that hollow microparticles (h-MPs) instead of solid microparticles (s-MPs), as peptide carriers, could improve the release efficiency, while better preserving their bioactivity.Methods
Glucagon like Peptide-1 (GLP-1) was encapsulated as a model peptide. Mass loss, average molecular weight changes, intraparticle pH, polymer-peptide interaction and release studies, together with bioactivity assessment of the peptide for s-MPs and h-MPs were systematically analyzed and evaluated for efficacy.Results
The intraparticle pH of s-MPs was as low as 2.64 whereas the pH of h-MPs was 4.99 by day 7. Consequently, 93% of the peptide extracted from h-MPs was still bioactive while only 58% of the peptide extracted from s-MPs was bioactive. Likewise, the cumulative release of GLP-1 by day 14 from h-MPs showed a cumulative amount of 88?±?8% as compared to 33?±?6% for s-MPs.Conclusions
The cumulative release of peptide can be significantly improved, and the bioactivity can be better preserved by simply using h-MPs instead of s-MPs as carriers.57.
Lev Gorfinkel Franziska Wachter Hong-yuan Luo Eileen Hansbury David A. Williams Archana Agarwal David H. K. Chui Alan B. Cantor 《Pediatric blood & cancer》2023,70(1):e30067
Unstable gamma globin variants can cause transient neonatal hemolytic anemia. We have identified a novel variant in a newborn who presented with jaundice and anemia requiring phototherapy and red blood cell transfusion. The patient was found to be heterozygous for the mutation HGB2:c.290T>C, p.Leu97Pro, which we have termed hemoglobin (Hb) Wareham. This substitution is expected to generate an unstable hemoglobin with increased oxygen affinity based on the homologous mutation previously described in the beta globin gene, which is termed as Hb Debrousse. The patient fully recovered by 9 months of age as expected with the transition from fetal to adult hemoglobin. 相似文献
58.
59.